Tnf
Tnf is a gene encoding tumor necrosis factor alpha (TNF-α), a pro-inflammatory cytokine involved in regulation of the inflammatory response.
Tnf is a gene encoding tumor necrosis factor alpha (TNF-α), a pro-inflammatory cytokine involved in regulation of the inflammatory response. TNF-α is studied in association with other mediators, including interleukin-6 (IL-6), CCL2 and interleukin-1β (IL-1β), and with signaling networks such as NF-κB, MAPK and PI3K–AKT. Recent work has examined TNF-α in neuroinflammation, airway inflammation mediated by ILC2s, spinal cord injury, skin inflammation and age-related systemic inflammation. In aging mice, circulating TNF-α has been associated with blood-based epigenetic age and targeted CpG methylation signatures.
Tnf is also an experimental therapeutic target. Small interfering RNA directed against TNF-α has been incorporated into lipid nanoparticles, hybrid lipid–polymeric nanoparticles and dissolving microneedles, including formulations combined with coenzyme Q10 or dexamethasone for localized skin treatment of psoriasis and other inflammatory conditions. Botanical and compound-based interventions have likewise been investigated through network pharmacology and pathway analyses that nominate TNF alongside targets such as MMP9, PTGS2, SRC and AKT1. These applications remain principally preclinical and focus on reducing cytokine-driven inflammation and downstream inflammatory signaling.
Where the papers sit
10 papers from the last 6 months study tnf directly · updated from PubMed 13 Nov 2026
Study type 0 clinical trials · 1 observational · 8 preclinical · 1 unclassified
Themes 3 themes · 1 new direction
-
Natural Products for Inflammation
Natural products are being developed as multi-target anti-inflammatory therapies across neuroinflammation, wound healing and metal-associated injury. Ginsenoside Rg1, methylophiopogonanone B, Ciwujia preparations and Panax notoginseng recur as candidate agents. TNF-associated pathways, NF-κB signaling and oxidative stress provide recurring mechanistic targets. Evidence remains mainly preclinical, combining pathway prediction with molecular and protein-level validation.
5 papers · 50%
-
Targeted Inflammation Pathways
TNF-linked inflammation connects aging biomarkers with asthma and ulcerative colitis. Circulating TNF-α, CCL2 and IL-6 track epigenetic age in mice, while arginine metabolism and NF-κB shape ILC2 airway inflammation. Non-ATP-competitive MKK3 inhibition is being pursued to suppress TNF-α production in ulcerative colitis. The cluster spans inflammatory biomarker definition and pathway-directed therapy rather than one disease.
3 papers · 30%
-
siRNA Delivery for Psoriasis
Psoriasis therapy is moving toward localized delivery of TNF-silencing RNA with complementary anti-inflammatory agents. Lipid nanoparticles and dissolving microneedles are used to deliver siTNF-α to skin. Dexamethasone or coenzyme Q10 is paired with siRNA to combine cytokine suppression with broader anti-inflammatory or antioxidant activity. The shared goal is more effective topical treatment while limiting systemic exposure.
2 papers · 20%
TNF-α is linked to epigenetic aging in addition to inflammatory disease processes
The aging-mice study found that circulating TNF-α was independently associated with blood-based epigenetic age and with targeted CpG methylation signatures, extending TNF-α’s role beyond the inflammatory mediator, pathway component, and disease biomarker categories used elsewhere in the set 42838293Oct. The finding changes the account by positioning TNF-α as a correlate of systemic epigenetic aging and a possible link between inflammaging and age-related epigenetic remodeling, although the abstract establishes association rather than causation.
Papers
The 10 papers from the last 6 months that study tnf directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Natural Products for Inflammation (5)
- Compound Ciwujia Granules Attenuate Stress-Induced Anxiety- and Depression-Like Behaviors via Inhibition of TNF-α-Associated Neuroinflammation in the dmPFC. CNS neuroscience & therapeutics · 1 Oct 2026 PMID 42817052
- An Integrated Strategy for Decoding Bioactive Components and Mechanism of Jingtong Granules: Chemical Characterization, Network Analysis, Pharmacokinetic and Pharmacodynamic Studies. Biomedical chromatography : BMC · 17 Sept 2026 PMID 42750651
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
- Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
- Integrated GNPS Molecular Networking and Network Pharmacology Uncover Methylophiopogonanone B as a Novel Anti-Inflammatory Agent From Polygonatum cyrtonema Hua Targeting the SRC-PI3K-Akt Pathway. Biomedical chromatography : BMC · 22 Jul 2026 PMID 42484235
Targeted Inflammation Pathways (3)
- Design and Synthesis of Novel, Non-ATP-Competitive MKK3 Modulators as Suppressors of TNF-α Production for the Treatment of Ulcerative Colitis. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018599
- Circulating TNF-α, CCL2 and IL-6 are associated with blood-based epigenetic age and targeted CpG methylation signatures in aging mice. Experimental gerontology · 6 Oct 2026 PMID 42838293
- Arginine metabolism and the NF-ĸB pathway jointly regulate the airway inflammation in asthma mediated by ILC2s. International immunopharmacology · 10 Jun 2026 PMID 42269551
siRNA Delivery for Psoriasis (2)
- Dissolving Microneedles Loaded with Lipid Nanoparticles for Co-Delivery of siTNF-α and Dexamethasone as a Dual-Action Therapy for Psoriasis. ACS applied materials & interfaces · 14 Sept 2026 PMID 42735507
- A dual functional hybrid lipid-polymeric nanoparticle co-loaded coenzyme Q10 and siRNA TNFα for anti-inflammatory skin therapy. International journal of pharmaceutics · 4 Sept 2026 PMID 42697387
By study type
Observational studies and case reports (1)
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
Preclinical: animal, cell and lab studies (8)
- Design and Synthesis of Novel, Non-ATP-Competitive MKK3 Modulators as Suppressors of TNF-α Production for the Treatment of Ulcerative Colitis. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018599
- Circulating TNF-α, CCL2 and IL-6 are associated with blood-based epigenetic age and targeted CpG methylation signatures in aging mice. Experimental gerontology · 6 Oct 2026 PMID 42838293
- Compound Ciwujia Granules Attenuate Stress-Induced Anxiety- and Depression-Like Behaviors via Inhibition of TNF-α-Associated Neuroinflammation in the dmPFC. CNS neuroscience & therapeutics · 1 Oct 2026 PMID 42817052
- An Integrated Strategy for Decoding Bioactive Components and Mechanism of Jingtong Granules: Chemical Characterization, Network Analysis, Pharmacokinetic and Pharmacodynamic Studies. Biomedical chromatography : BMC · 17 Sept 2026 PMID 42750651
- A dual functional hybrid lipid-polymeric nanoparticle co-loaded coenzyme Q10 and siRNA TNFα for anti-inflammatory skin therapy. International journal of pharmaceutics · 4 Sept 2026 PMID 42697387
- Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
- Integrated GNPS Molecular Networking and Network Pharmacology Uncover Methylophiopogonanone B as a Novel Anti-Inflammatory Agent From Polygonatum cyrtonema Hua Targeting the SRC-PI3K-Akt Pathway. Biomedical chromatography : BMC · 22 Jul 2026 PMID 42484235
- Arginine metabolism and the NF-ĸB pathway jointly regulate the airway inflammation in asthma mediated by ILC2s. International immunopharmacology · 10 Jun 2026 PMID 42269551
Unclassified: not yet indexed with MeSH (1)
- Dissolving Microneedles Loaded with Lipid Nanoparticles for Co-Delivery of siTNF-α and Dexamethasone as a Dual-Action Therapy for Psoriasis. ACS applied materials & interfaces · 14 Sept 2026 PMID 42735507
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-11-02. Drafted by language models from published abstracts; not medical advice.